• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Español
  • English
  • Bloglovin
  • Email
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube
CDE Almería – Centro de Documentación Europea – Universidad de Almería

CDE Almería - Centro de Documentación Europea - Universidad de Almería

Centro de Documentación Europea de la Universidad de Almería

  • HOME
  • WHAT´S ON
    • EU BULLETINS
    • EU NEWS
    • Activities
    • EU Calls and Awards
    • Radio Program «Europe with You»
  • DOCUMENTATION
    • Bibliographic Collection
      • Almería EDC Digital Collection
      • UNIVERSITY OF ALMERIA LIBRARY
    • Documentation by topic
    • EU Media Collection
      • Web Space
      • MEDIATHEQUE REPOSITORY
  • Europe on the net
    • Institutions
    • EU Representation in Spain
    • European information network of Andalusia
    • EU official journal
  • ABOUT US
    • Presentation
    • People
    • Contact

Agreement with Moderna to adapt delivery schedules

Inicio » Noticias UE » Sanidad » Diseases » Agreement with Moderna to adapt delivery schedules

06/06/2022

Agreement with Moderna to adapt delivery schedules

The European Commission and the vaccine developer Moderna have reached an agreement to ensure that the delivery of COVID-19 vaccines is adapted to the needs of Member States. On the basis of this agreement, the company will postpone the delivery of some doses initially planned for quarter 2 of 2022, to later in the year. In addition, should an adapted vaccine receive an EU marketing authorisation following the assessment of the European Medicines Agency, a part of the doses scheduled for April, May and June may be delivered as booster vaccines adapted to the current COVID-19 variants from September and during the autumn and winter months of 2022.

The agreement will also allow the delivery of vaccines adapted to future variants, again after approval by the European Medicines Agency, so that Member States can respond to any epidemiological developments later this year and continue to support partner countries globally.

This amendment is part of an ongoing process whereby the Commission and Member States are working closely with the EU’s vaccine suppliers to address the evolving pandemic needs. The Commission intends to finalise further such agreements in the near future.

Background

In 2020, the European Union invested heavily in the global production of a number of COVID-19 vaccines. It was crucial to have vaccines as early as possible and at the scale needed, requiring important investments before knowing whether any of these vaccines would prove successful.

These actions taken at risk in 2020 have clearly paid off, as the development of vaccines has been quite successful: of the eight vaccines in the EU’s vaccines portfolio, five have received marketing authorisation, two are still under review, and only one has been terminated before reaching further stages.

EU Member States have access to safe and effective vaccines early, and at the scale needed, allowing all EU citizens to be offered primary and booster vaccinations, saving lives and mitigating the impact of the pandemic upon social and economic life.

Moreover, a large number of these vaccines could also be used in the global efforts to tackle the pandemic. Around two-thirds of vaccine doses produced in the EU – more than 2 billion vaccine doses – have been exported to 167 countries. Member States have shared almost 475 million doses of which around 364 million have already been delivered to recipient countries (around 85% of these via COVAX).

At the same time, Member States must continue to ensure they have the strategic stocks of vaccines they need to deal with the potential epidemiological evolution of the COVID-19 virus. This includes having supply contracts, which allow for the supply of adapted vaccines, should they prove necessary.

In cooperation with the manufacturers, the Commission continues to facilitate further exchanges of doses between Member States to better address their needs, especially for the autumn and winter season.

New agreement to recognise COVID-19 as an occupational disease

More information

European Commission – News

Publicaciones relacionadas:

European Commission authorises second safe and effective vaccine against COVID-19 SARS-CoV-2 mutations thwart body’s killer cells New agreement to recognise COVID-19 as an occupational disease Commission approves second Spanish “umbrella” scheme to support economy in coronavirus outbreak Spring 2020 Economic Forecast: A deep and uneven recession, an uncertain recovery

“This is a space for debate. All comments, for or against publication, that are respectful and do not contain expressions that are discriminatory, defamatory or contrary to current legislation will be published”.

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Primary Sidebar

Publicaciones relacionadas

European Commission authorises second safe and effective vaccine against COVID-19 SARS-CoV-2 mutations thwart body’s killer cells New agreement to recognise COVID-19 as an occupational disease Commission approves second Spanish “umbrella” scheme to support economy in coronavirus outbreak Spring 2020 Economic Forecast: A deep and uneven recession, an uncertain recovery

Footer

Logotipo en negativo del Centro de Documentación Europea de Almería

CDE Almería
Edificio Parque Científico-Tecnológico (Pita)
Planta: 1ª, Despacho: 29
04120. Ctra. Sacramento s/n. Almería (Spain)
Teléfono: (+34) 950 015266

Navegación

INICIO
ACTUALIDAD
DOCUMENTACIÓN
EUROPA EN LA RED
CONÓCENOS
ACCESIBILIDAD
MAPA DE SITIO
AYUDA AL USUARIO

AVISO LEGAL
POLÍTICA DE PRIVACIDAD
POLÍTICA DE COOKIES

Copyright © 2022 CDE Almería · <a href=”http://creativecommons.org/licenses/by-nc/4.0/” rel=”license”><img class=”alignright” style=”border-width: 0;” src=”https://i.creativecommons.org/l/by-nc/4.0/88×31.png” alt=”Creative Commons License” /></a>This work is licensed under a <a href=”http://creativecommons.org/licenses/by-nc/4.0/” rel=”license”>Creative Commons Attribution-NonCommercial 4.0 International License</a>.

<p>El Centro de Documentación Europea de la Universidad de Almería utiliza cookies propias y de terceros para facilitar al usuario la navegación en su página Web y el acceso a los distintos contenidos alojados en la misma. Asimismo, se utilizan cookies analíticas de terceros para medir la interacción de los usuarios con el sitio Web. Pinche el siguiente enlace si desea información sobre el uso de cookies y como deshabilitarlas. ajustes</p>

Politica de privacidad

El Centro de Documentación Europea de la Universidad de Almería utiliza cookies propias y de terceros para facilitar al usuario la navegación en su página Web y el acceso a los distintos contenidos alojados en la misma. Asimismo, se utilizan cookies analíticas de terceros para medir la interacción de los usuarios con el sitio Web. Pinche el siguiente enlace si desea información sobre el uso de cookies y como deshabilitarlas. <a href="/politica-de-cookies" rel="noopener" target="_blank">Más información</a>

Cookies estrictamente necesarias

Las cookies estrictamente necesarias tiene que activarse siempre para que podamos guardar tus preferencias de ajustes de cookies.

Básicamente la web no funcionara bien si no las activas.

Estas cookies son:

  • Comprobación de inicio de sesión.
  • Cookies de seguridad.
  • Aceptación/rechazo previo de cookies.

Si desactivas esta cookie no podremos guardar tus preferencias. Esto significa que cada vez que visites esta web tendrás que activar o desactivar las cookies de nuevo.

Cookies de terceros

Esta web utiliza Google Analytics, Google Tag Manager y Yandex Metrika para recopilar información anónima tal como el número de visitantes del sitio, o las páginas más populares.

Dejar estas cookies activas nos permite mejorar nuestra web.

¡Por favor, activa primero las cookies estrictamente necesarias para que podamos guardar tus preferencias!

Política de cookies

Pinche el siguiente enlace si desea información sobre el uso de cookies y como deshabilitarlas. Más información